Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Integrating AI-Driven Analysis of Clinical and Imaging Data to Optimize Lung Cancer Treatment Strategies Ricardo Gonzales Vera University of Oxford PLCO Apr 2, 2024 PLCOI-1517
WARIFA - Watching the Risk Factors Giovanni Sebastiani Institute for applied mathematics "Mauro Picone" (IAC) PLCO Apr 2, 2024 PLCO-1521
AI-assisted Lung Nodule Detection in Radiology Anita Blazevic FH Technikum Vienna NLST Mar 27, 2024 NLST-1215
Covariate data for new set of controls for GWAS studies Rachael Stolzenberg-Solomon DCEG, NCI PLCO Mar 27, 2024 PLCO-1515
Enhancing Lung Cancer Treatment Decisions through AI-driven Analysis of PLCO Patient Data Ricardo Gonzales Vera University of Oxford PLCO Mar 27, 2024 PLCO-1514
Adherence to the EAT-Lancet dietary pattern reduces the risk of renal cancer in the PLCO Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO Mar 27, 2024 PLCO-1513
Improving risk stratification of uncertain pulmonary nodules based on deep learning method yulu Wu zhongyuan university of technology NLST Mar 25, 2024 NLST-1219
Lung Cancer Classification Based On Sequential Image Wu Kang Taiyuan University of Technology NLST Mar 25, 2024 NLST-1218
Topological biomarker in lung adenocarcinoma Senyi Deng West China Hospital NLST Mar 25, 2024 NLST-1209
A Hybrid Classical-Quantum Neural Network to Predict Future Lung Cancer Risk From a Single Low-Dose CT Weixin Lu New York University NLST Mar 25, 2024 NLST-1208
XECAN and Rescue Lung CTLS Registry Bin Yang XECAN Smart Safe Oncology NLST Mar 25, 2024 NLST-1203
Pan-cancer analyses of imaging-clinical phenotype associations using updated PLCO cohorts Kun-Hsing Yu President and Fellows of Harvard College PLCO Mar 25, 2024 PLCOI-1509
Clarifying Lung Cancer Risk Among Prostate Cancer Survivors Keith Sigel Icahn School of Medicine at Mount Sinai PLCO Mar 25, 2024 PLCO-1508
Identifying novel genetic factors predisposing to inherited cardiac disorders Connie Bezzina Amsterdam Universitair Medisch Centrum PLCO Mar 25, 2024 PLCO-1507
Anthocyanin and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort Huijun Huang Wenzhou medical university PLCO Mar 25, 2024 PLCO-1506
Advancing Lung Cancer Detection: Harnessing PLCO Trial X-Ray Imagery for Improved Diagnostic Algorithms Piyush Samant Mirxes Labs Pte. Ltd., Singapore PLCO Mar 25, 2024 PLCOI-1503
Low carbohydrate dietary score and prostate, ovarian, and lung cancer incidence Maryam Farvid George Mason University PLCO Mar 25, 2024 PLCO-1501
Lung and Cardiovascular Disease Detection with Large Scale, Disease Screening Chest X-rays Pingkun Yan Rensselaer Polytechnic Institute PLCO Mar 25, 2024 PLCOI-1505
A metabolomics-based multidimensional deep learning model for predicting the risk of malignancy in pulmonary nodules Zhixia Su Yangzhou University PLCO Mar 25, 2024 PLCO-1498
Comparison of net endogenous acid production from dietary self-report instruments against recovery biomarker-derived measures Douglas Chang National Institute of Diabetes and Digestive and Kidney Diseases IDATA Mar 21, 2024 IDATA-71